#CNBC Why cheaper GLP-1 drugs are facing legal battles

Why cheaper GLP-1 drugs are facing legal battles
The push to make weight-loss drugs more affordable is running into legal limits. Telehealth company Hims & Hers pulled a less expensive oral version of Wegovy after lawsuits from Novo Nordisk and rising regulatory scrutiny. The dispute centers on pharmaceutical compounding.

CNBC’s Brandon Gomez explains what that means.

Thank you for your support in keeping this website running.💛

View on “Tokyo Trend News”